Breaking News Instant updates and real-time market news.

MU

Micron

$17.80

0.07 (0.39%)

, AMAT

Applied Materials

$29.61

-0.31 (-1.04%)

07:24
10/05/16
10/05
07:24
10/05/16
07:24

Micron report reads positively for Applied Materials, Lam, says RBC Capital

Following Micron's (MU) quarterly report and guidance, RBC Capital Amit Daryanani said he sees positive read-through from the report for Applied Materials (AMAT), Lam Research (LRCX), ASML (ASML), Western Digital (WDC) and Intel (INTC). Micron management expects capex spending of $4.8B-$5.2B for FY17, noted Daryanani, who believes continued 3D NAND spending will benefit Applied and Lam the most.

MU

Micron

$17.80

0.07 (0.39%)

AMAT

Applied Materials

$29.61

-0.31 (-1.04%)

LRCX

Lam Research

$94.83

0.24 (0.25%)

ASML

ASML

$108.96

0.03 (0.03%)

WDC

Western Digital

$58.69

-0.17 (-0.29%)

INTC

Intel

$37.54

-0.12 (-0.32%)

  • 19

    Oct

  • 19

    Oct

  • 26

    Oct

  • 14

    Nov

  • 18

    Nov

MU Micron
$17.80

0.07 (0.39%)

10/05/16
DBAB
10/05/16
NO CHANGE
Target $20
DBAB
Buy
Micron guidance likely to cause disappointment, says Deutsche Bank
Deutsche Bank analyst Sidney Ho says Micron's guidance for Q1 is likely to cause "investor confusion and disappointment" as the majority of the improvement comes from a change in accounting and non-GAAP calculation, rather than better pricing and margins. The analyst, however, still believes market conditions for both DRAM and NAND are improving and that Micron is positioned to benefit from new products. Ho reiterates a Buy rating on the shares with a $20 price target.
10/05/16
BMUR
10/05/16
NO CHANGE
Target $23
BMUR
Buy
Micron price target raised to $23 from $18 at Brean Capital
Brean Capital analyst Mike Burton raised his price target for Micron Technology to $23 saying the company last night delivered a "strong" top-line growth and better earnings quarter than the Street expected. The analyst, however, views the quality of the guidance raise as "poor" considering Micron is changing some of its accounting practices. Burton continues to like Micron and keeps a Buy rating on the shares.
10/03/16
MSCO
10/03/16
NO CHANGE
MSCO
Overweight
Morgan Stanley continues to recommend buying Micron
Morgan Stanley analyst Joseph Moore recommends to continue buying Micron given the strong pricing backdrop and strong DRAM bit growth the last 2 quarters, which should drive an earnings inflection higher. Moore sees upside to Q1 numbers and an upward revision to his FY17 $1.22 estimate as he expects DRAM pricing to remain strong, with NAND a bit more mixed, for the next several quarters. The analyst is not making a trade into tomorrow's report due to lack of transparency into guidance, but recommends buying shares into a strong November quarter and beyond. Moore rates Micron a Buy with a $20 price target on shares.
09/29/16
NOMU
09/29/16
NO CHANGE
Target $23
NOMU
Buy
Nomura remains a Buyer of Micron, especially on weakness
Nomura analyst Romit Shah believes we are in the early part of a positive earnings revision cycle for Micron. The analyst raised his November earnings estimate to 17c, above consensus of 8c, but below "perceived" consensus of 20c-25c. Shah said DRAM's pricing outlook is the key driver as pricing and mix are improving. The analyst remains a buyer of Micron and reiterates his Buy rating and $23 price target.
AMAT Applied Materials
$29.61

-0.31 (-1.04%)

09/13/16
GSCO
09/13/16
NO CHANGE
Target $33
GSCO
Conviction Buy
Goldman bullish into Applied Materials' analyst day
Goldman analyst Toshiya Hari is bullish on Applied Materials going into its September 21 analyst day as he expects management to point to healthy industry fundamentals and specific growth opportunities. Hari expects a meaningful increase in the company's long-term earnings target to $2.75 from $2.00 at the midpont and for consensus estimates to move higher. The analyst rates Applied Materials a Conviction Buy with a $33 price target.
09/15/16
STFL
09/15/16
NO CHANGE
STFL
Applied Materials poised to benefit from VR, AR, says Stifel
Stifel analyst Patrick Ho says that augmented reality and virtual reality should boost Applied Materials' semiconductor equipment and display equipment businesses. The proliferation of "more real-life" VR and AR applications beginning in 2019-2020 should lead to "additional wafer starts and an acceleration of OLED capacity in the industry," lifting Applied Materials' results, according to the analyst. He says that the company's leadership positions in both areas make it the best positioned in the sector to benefit from AR and VR He keeps a Buy rating on the shares.
10/04/16
GSCO
10/04/16
DOWNGRADE
GSCO
Buy
Applied Materials downgraded to Buy from Conviction Buy at Goldman
Goldman analyst Toshiya Hari removed Applied Materials from the Conviction Buy List due to relative outperformance. The analyst maintains a Buy rating and $33 price target on shares given strong industry fundamentals, market share gains, opportunity in mobile display, a strong management team, and upside to Street estimates.
09/19/16
SBSH
09/19/16
NO CHANGE
Target $37
SBSH
Buy
Applied Materials price target raised to $37 from $32 at Citi
Citi analyst Atif Malik raised his price target for Applied Materials to $37 ahead of the company's investor day on September 21. The analyst sees multiple expansion with "spend drivers like 3D NAND, China, and OLED" remaining "in early innings," Malik tells investors in a research note. He reiterates a Buy rating on Applied Materials.
LRCX Lam Research
$94.83

0.24 (0.25%)

09/08/16
SBSH
09/08/16
NO CHANGE
Target $102
SBSH
Buy
Citi stil sees risk in Lam, KLA-Tencor merger deal
Dealreporter yesterday published an article yesterday stating that Lam Research (LRCX) is in discussions with China's MOFCOM to resolve deal concerns, Citi analyst Atif Malik tells investors in a research note. The analyst continues to see risk in Lam, KLA-Tencor (KLAC) deal on decreased competition concerns with regulators. He adds that equipment peers at the Citi Technology conference this week spoke of concentration concerns with the deal. Malik has a Buy rating on Lam with a $102 price target.
08/29/16
08/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. T-Mobile (TMUS) upgraded to Outperform from Market Perform at Wells Fargo, with analyst Jennifer Fritzsche saying the company's free cash flow should ramp significantly in 2017. T-Mobile should also see continued positive momentum in subscriber growth and be helped by M&A speculation post the Presidential election, said Fritzsche, who raised her price target range for the shares to $52-$54 from $48-$50. 2. KLA-Tencor (KLAC) upgraded to Outperform from Market Perform at Cowen by analyst Timothy Arcuri, who views the shares as "too interesting to ignore" regardless of the Lam Research (LRCX) deal outcome. KLA's risk/reward, even if the deal breaks, is now 3:1 to the upside, which is hard to find in semis, Arcuri tells investors in a research note. 3. Allegheny Technologies (ATI) upgraded to Buy from Hold at Deutsche Bank, with Deutsche Bank analyst Jorge Beristain saying leverage concerns have eased following the closure of the company's Rowley facility. Management is acting to exit low-margin stainless products, said Beristain. 4. CBL & Associates (CBL) upgraded to Buy from Hold at Jefferies, as analyst Omotayo Okusanya thinks "several issues" that have been an overhang on the shares are now resolved or are in the process of resolution. The company's portfolio quality is rising while its balance sheet is in better shape, Okusanya tells investors. 5. AstraZeneca upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/29/16
COWN
08/29/16
UPGRADE
Target $80
COWN
Outperform
KLA-Tencor upgraded to Outperform from Market Perform at Cowen
Cowen analyst Timothy Arcuri upgraded KLA-Tencor (KLAC) to Outperform saying the shares are now "too interesting to ignore" regardless of the Lam Research (LRCX) deal outcome. KLA's risk/reward, even if the deal breaks, is now 3:1 to the upside, which is hard to find in semis, Arcuri tells investors in a research note. Intel (INTC) pushback likely explains recent deal delays, the analyst contends. He has an $80 price target for KLA-Tencor shares.
08/24/16
SBSH
08/24/16
NO CHANGE
SBSH
Lam Research, KLA-Tencor remain committed to deal, says Citi
Citi analyst Atif Malik said that after attending a roadshow with Lam Research (LRCX), one of his key takeaways was that there is no change in the commitment from Lam or KLA-Tencor (KLAC) management to their deal, so long as they can overcome regulatory concerns. Additionally, the analyst noted that Lam expects 3D NAND wafer starts to be towards the high-end of expectations this year and sees gain 7-10 pts overall in share on 3D NAND versus 2D.
ASML ASML
$108.96

0.03 (0.03%)

08/17/16
BOFA
08/17/16
DOWNGRADE
BOFA
Neutral
ASML downgraded to Neutral from Buy at BofA/Merrill
08/17/16
08/17/16
DOWNGRADE
Target $99

Neutral
ASML downgraded following Intel EUV reductions at BofA/Merrill
As previously reported, BofA/Merrill downgraded ASML to Neutral from Buy and lowered its price target $99 from $112. Analyst Kal Korschelt said Intel (INTC) implied last night at the Intel Developer Forum that it will pursue its initial 7nm ramp in 2018/19 without Extreme Ultraviolet Lithography Technology, or EUV. The analyst said this implies reduced demand for ASML's (ASML) EUV tools from Intel in 2017-19 and lowered 2017-18 earnings by 8% to 13%. Further, Korschelt said the semicapex cycle is likely to moderate into 2017 and for ASML shares to take a breather after strong outperformance.
08/23/16
BERN
08/23/16
NO CHANGE
BERN
ASML weakness due to 'gross misinterpretation,' says Bernstein
Bernstein analyst Pierre Ferragu says that "a gross misinterpretation" of Intel's (INTC) comments about EUV caused a decline of over 7% in ASML's stock. Specifically, an Intel employee said that the company was looking to convert some layers of 7nm to EUV, Ferragu reported. However, other firms erroneously stated that Intel plans to initially design its 7nm without EUV, Ferragu stated. The analyst does not believe that the company's actually statement represents a new position compared with last November. He keeps a $138 price target and Outperform rating on ASML.
07/21/16
07/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Navient (NAVI) downgraded to Neutral from Buy at Goldman with analyst Eric Beardsley saying the risk/reward is more balanced at current share levels. 2. Ericsson (ERIC) downgraded to Neutral from Buy at UBS with the firm citing a lack of revenue stabilization in the second quarter and little management commentary stating it would change. 3. Graco (GGG) downgraded to Market Perform from Outperform at William Blair with analyst Nicholas Heymann citing the company's transition after it cut its fiscal 2016 organic growth view. 4. ASML (ASML) downgraded to Neutral from Buy at UBS with analyst Gareth Jenkins stating he thinks ASML shares are now discounting some of the recent positive developments on EUV lithography following a 28% rally since January. 5. Boardwalk Pipeline (BWP) downgraded to Neutral from Buy at Ladenburg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WDC Western Digital
$58.69

-0.17 (-0.29%)

10/04/16
SBSH
10/04/16
NO CHANGE
Target $70
SBSH
Buy
Western Digital price target raised to $70 from $65 at Citi
Citi analyst Stanley Kovler raised his price target for Western Digital (WDC) to $70 saying he remains constructive on near-term hard-disk-drive and NAND trends heading into the Q3 earnings season. The analyst sees improved pricing in both sectors and believes the company is executing on its SanDisk integration. He keeps a Buy rating on the shares. Kovler also upped his price target for Neutral-rated Seagate (STX) to $37 from $29.
09/28/16
BMUR
09/28/16
NO CHANGE
Target $42
BMUR
Buy
Brean says surveillance a bigger, faster growing drive opportunity than realized
After meeting with executives from Seagate (STX) to discuss the video surveillance market, Brean Capital analyst Ananda Baruah acknowledged that he know believes the market is developing as potentially a much stronger revenue and margin opportunity for the company and peer Western Digital (WDC) than he'd realized. Video surveillance may account for at least 15%-20% of Seagate capacity shipped in 4-5 years and gross margin in the segment is currently about 200bp stronger than corporate average, said Baruah. The analyst, who estimates Seagate could ultimately generate $4.00-$6.00 in annual normalized EPS, keeps a Buy rating and $42 price target on the stock.
09/29/16
LEHM
09/29/16
NO CHANGE
Target $61
LEHM
Overweight
Western Digital is a new Top Pick in IT Hardware at Barclays
Barclays analyst Mark Moskowitz recommends investors build positions in Western Digital (WDC) and named it his new Top Pick in IT Hardware, removing Apple (AAPL). Western Digital issued a positive September quarter financial update citing a favorable mix in both HDD and SSD, and particularly good pricing conditions in NAND flash, the analyst wrote. Moskowitz believes the company's commentary is positive for investor sentiment and added it to the top spot given improving end markets, reduced industry manufacturing capacity, and potential for further operational synergies. He recommends investors build or add positions in Western Digital as gross margins should trend upward in the near- to mid-term. Moskowitz rates Western Digital an Overweight with a $61 price target on shares.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $65
RBCM
Outperform
Western Digital see upside to recent preannouncement at RBC Capital
RBC Capital analyst Amit Daryanani raised his September quarter and FY17 estimates ahead of Western Digital s already preannounced range and sees sustainable tailwinds across its HDD and NAND portfolio. Daryanani sees 5%-10% earnings upside versus the early positive preannouncement in early September and believes shares can continue to inflect higher through the end of CY16 from better PC + Hyperscale tailwinds driving core HDD, NAND demand uptick, acquisition cost take-out benefits, and tailwinds from lower interest expense and potential tax rate as well. The analyst rates Western Digital an Outperform and raised his price target to $65 from $60 on shares.
INTC Intel
$37.54

-0.12 (-0.32%)

09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
ADAM
09/20/16
NO CHANGE
Target $44
ADAM
Buy
Intel price target raised to $44 from $40 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Intel to $44 from $40 following the company's positive pre-announcement. The analyst increased his estimates as well and said with its attractive dividend yield and valuation, Intel should be a core holding for investors. Ramsay reiterated his Buy rating on Intel shares.
09/20/16
BMUR
09/20/16
NO CHANGE
Target $40
BMUR
Buy
Intel guidance raise not a surprise, says Brean Capital
Brean Capital analyst Mike Burton noted Intel raised its guidance last week citing the replenishment of the PC supply chain inventory and improving PC demand. The analyst said he was not surprised by the announcement given anecdotal positive data from many of the suppliers in the sector. Burton believes Intel remains well positioned and so reiterated his Buy rating and increased his price target to $40 from $38 on Intel shares.
09/20/16
SUSQ
09/20/16
INITIATION
Target $42
SUSQ
Positive
Intel initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Intel with a Positive and a $42 price target saying the company has the ability to extract value through process leadership and the best wafer manufacturing in the world.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.